Karen T. Adams
Auckland University of Technology(NZ)
Publications by Year
Research Areas
Adrenal and Paraganglionic Tumors, Cancer, Hypoxia, and Metabolism, Pituitary Gland Disorders and Treatments, Hormonal Regulation and Hypertension, Neuroblastoma Research and Treatments
Most-Cited Works
- → Comparison of 18F-Fluoro-L-DOPA, 18F-Fluoro-Deoxyglucose, and 18F-Fluorodopamine PET and 123I-MIBG Scintigraphy in the Localization of Pheochromocytoma and Paraganglioma(2009)389 cited
- → Plasma methoxytyramine: A novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status(2011)367 cited
- → Novel patterns of gene expression in polyploid plants(2005)338 cited
- → Superiority of Fluorodeoxyglucose Positron Emission Tomography to Other Functional Imaging Techniques in the Evaluation of Metastatic SDHB-Associated Pheochromocytoma and Paraganglioma(2007)334 cited
- → High Frequency ofSDHBGermline Mutations in Patients with Malignant Catecholamine-Producing Paragangliomas: Implications for Genetic Testing(2006)313 cited
- → Measurements of Plasma Methoxytyramine, Normetanephrine, and Metanephrine as Discriminators of Different Hereditary Forms of Pheochromocytoma(2011)292 cited
- → Clinical Presentations, Biochemical Phenotypes, and Genotype-Phenotype Correlations in Patients withSuccinate Dehydrogenase Subunit B-Associated Pheochromocytomas and Paragangliomas(2007)274 cited
- → Staging and Functional Characterization of Pheochromocytoma and Paraganglioma by 18F-Fluorodeoxyglucose (18F-FDG) Positron Emission Tomography(2012)272 cited
- → Superiority of [68Ga]-DOTATATE PET/CT to Other Functional Imaging Modalities in the Localization of SDHB -Associated Metastatic Pheochromocytoma and Paraganglioma(2015)264 cited
- → Biochemical and Clinical Manifestations of Dopamine-Producing Paragangliomas: Utility of Plasma Methoxytyramine(2005)235 cited